Nanoparticles as a drug delivery system enables unique approaches for cancer treatment. Over the last two decades, a lar...
Singapore: Prima BioMed's interim data from the CAN-003 phase II clinical trial of cancer vaccine therapy, CVac, which ...
Singapore: Starpharma reported net cash outflows from operating and investing activities for the year ending June 30, 20...
Singapore: South Australian biotechnology company, GeneWorks, developed a new DNA barcoding technology for use as a secu...
Singapore: Australia based Bionomics is recognized as the Innovative Asian Biotech of the Year at BioPharma Asia Industr...
Singapore: Regenerative medicine company Mesoblast's phase II clinical trial for lumbar spinal fusion successfully met ...
Singapore: US-based Vertex Pharmaceuticals has received Therapeutic Goods Administration (TGA) of Australia approval of ...
Singapore: A team of Australian scientists discovered new genes that show identifiable changes in the blood of people wi...
Singapore: Algae.Tec, an Australian biofuels company, has appointed Mr Colin McGregor as general manager project operati...
Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: 'Peptide inhibitors of c-Jun dimeriz...
Singapore: Irish medtech firm Mainstay Medical has started its clinical trials on Implanted Reactiv8 unit that is being ...
Singapore: International investment bank, Canaccord Genuity, expanded its Australian operations with the addition of a ...
The research and development (R&D) spend in Asia Pacific in 2011 was down by 50 percent to an average of 6.58 percen...
Singapore: The board of Genetic Technologies (GTG) has appointed Ms Alison Mew as the permanent chief executive officer...
Singapore: The Australian Institute of Health and Welfare (AIHW) has presented a report that showed that though health c...
Lack of appropriate funding for early- to mid-stage innovation companies, limited local capital, local grants for small ...
‎Singapore: Australia-based CSL Behring achieved improved pharmacokinetic results for its novel investigational re...
Singapore: Living Cell Technologies has appointed Dr Paul Tan as its chief science and medical officer. As CSMO, Dr Tan...
